Market Movers | Winners: AIAI, ARCT, TMC | Losers: ZIP, NUAI, SA
Beneath a quiet surface for the major indexes, a few stocks made moves that demand a closer look.
AIAI (AIAI) was the day’s strongest stock, returning +46.1%. The move came on a day of modest gains for the major indexes, with the S&P 500 returning +0.4%, the Dow Jones Industrial Average up +1.0%, and the Nasdaq-100 adding +0.3%.
When the market is calm but single stocks are not, the immediate question is whether these are fleeting pops or signs of durable momentum. The day’s biggest winners and losers are below.
Friday’s Market Winners
The 6 stocks with the highest returns on the last trading day:
| # | Ticker | Company Name | 1-D Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | AIAI | AIAI | 46.1% | n/a |
| 2 | ARCT | Arcturus Therapeutics | 22.4% | 119.4% |
| 3 | TMC | TMC The Metals | 20.7% | -22.4% |
| 4 | ELMT | Elmet | 19.3% | n/a |
| 5 | EMAT | Evolution Metals & Technologies | 19.2% | n/a |
| 6 | ISOU | IsoEnergy | 16.1% | 30.7% |
Friday’s Market Losers
And the 3 stocks with the lowest returns:
| # | Ticker | Company Name | 1-D Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | ZIP | ZipRecruiter | -18.6% | 7.9% |
| 2 | NUAI | New Era Energy & Digital | -12.8% | 65.7% |
| 3 | SA | Seabridge Gold | -9.3% | 1.9% |
What does a persistent move actually look like?
Arcturus Therapeutics (ARCT) offers a clear example. The stock appears on both the one-day and one-month winners lists, returning +22.4% today alone. Its one-month return is +132.3%. The data shows its strength is not a one-day event, separating it from names making their first appearance.
Movers Over The Last Week
Widening the window to five trading days, these are the strongest and weakest Market names:
| # | Ticker | Company Name | 1-W Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | MRNA | Moderna | 129.2% | 392.1% |
| 2 | AMLX | Amylyx Pharmaceuticals | 78.7% | 220.0% |
| 3 | ARCT | Arcturus Therapeutics | 63.4% | 119.4% |
| 4 | PURR | Hyperliquid Strategies | 58.4% | 197.2% |
| 5 | MRVI | Maravai LifeSciences | 51.6% | 165.8% |
| # | Ticker | Company Name | 1-W Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | EYPT | EyePoint | -63.9% | -70.9% |
| 2 | FTK | Flotek Industries | -31.1% | 43.2% |
Movers Over The Last Month
And over the last 21 trading days:
| # | Ticker | Company Name | 1-M Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | MRNA | Moderna | 154.5% | 392.1% |
| 2 | ARCT | Arcturus Therapeutics | 132.3% | 119.4% |
| 3 | AMLX | Amylyx Pharmaceuticals | 119.8% | 220.0% |
| 4 | RCEL | AVITA Medical | 118.2% | 191.6% |
| 5 | TEAM | Atlassian | 114.4% | 6.0% |
| # | Ticker | Company Name | 1-M Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | CAPR | Capricor Therapeutics | -68.3% | -78.2% |
| 2 | MPLT | MapLight Therapeutics | -68.2% | -36.2% |
| 3 | EYPT | EyePoint | -57.3% | -70.9% |
| 4 | BIOA | Bioage Labs | -56.7% | -28.3% |
So what is the disciplined next step?
A movers list is a map of market attention, not a set of instructions. The tables above show where capital and risk were most concentrated over three different time horizons. A large move simply flags a name for fundamental review.
Consider ZipRecruiter (ZIP), the day’s weakest stock with a return of -18.6%. A disciplined investor’s next click is not to sell, but to check the business context: its revenue grew 0.4% over the last twelve months and it trades at 12.3 times trailing earnings. This is the work that follows the leaderboard.
Either side of these lists can be a lead worth following, with the same follow-up question: does the business back the move? For the winners, our Guidance Momentum screen tracks which companies raised their own forward numbers. For the losers, our Buy the Dip screen flags which marked-down names still have the fundamentals to recover.
The Tape Rewards Attention. It Punishes Reaction
Big daily moves pull hard at both greed and fear, and acting on either, day after day, is how most portfolios end up trailing the index they were trying to beat.
The Trefis High Quality (HQ) Portfolio is built for the opposite reflex: about 30 quality businesses screened for the fundamentals that survive volatile stretches, held with rules instead of reactions. It has a track record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Read the movers daily; trade them rarely.